Sports Advisory Board

Troy Aikman

Sports Advisory Board Member

Troy Aikman is a Pro Football Hall of Fame quarterback, broadcaster, and entrepreneur best known for leading the Dallas Cowboys during their dominant run in the 1990s. Selected first overall in the 1989 NFL Draft, Aikman spent his entire 12-season career in Dallas. He guided the Cowboys to three Super Bowl championships—XXVII, XXVIII, and XXX—and was named MVP of Super Bowl XXVII after throwing four touchdown passes. A six-time Pro Bowl selection, he retired with 32,942 passing yards and was inducted into the Pro Football Hall of Fame in 2006.

Aikman transitioned directly into broadcasting, joining FOX Sports in 2001. Partnered with play-by-play announcer Joe Buck, he became one of football’s most recognizable and respected analysts. The pair moved to ESPN in 2022 to lead Monday Night Football and now form the longest-running lead NFL broadcast partnership in television history. Beyond broadcasting, Aikman is a successful entrepreneur and founder of EIGHT Elite Light Beer.

In recent years, Aikman has become increasingly focused on longevity and healthspan optimization. His disciplined routine incorporates training, nutrition, meditation, intermittent fasting, sleep prioritization, sauna, cold exposure, and red-light therapy—reflecting his stated goal of making his healthspan match his lifespan. Aikman longevity journey has led him MuseCell® Innovations to ensure he is at the forefront of the regenerative medicine industry.

← Team

US Customers

These products have not been evaluated or approved by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure, or prevent any disease or medical condition. In the United States, certain states permit the provision of certain stem cell therapies not approved by the FDA. Currently, the states of Florida, Georgia, Tennessee, and Utah, and Texas permit the provision of certain stem cell therapies, including Muse Cells, provided the various conditions of a particular state’s requirements are met. Any clinical use is at the sole discretion of a licensed healthcare provider and must comply with all applicable laws and regulations. Individual patient results may vary. No claims are made regarding safety or effectiveness for any specific clinical application.

Licensing & Trademark Integrity

As the global IP owner, MCI authorizes distribution only through approved partners who operate within a controlled, quality-assured framework. All legitimate Dezawa MuseCells® supplied to any market must originate from MCI’s manufacturing ecosystem and must be distributed through MCI-designated, licensed partners. This structure ensures that every Dezawa MuseCells® product regardless of country of delivery meets the highest scientific, ethical, and quality standards established by MCI and validated with ongoing global clinical research.

Legal Disclaimer

Dezawa High Performance™ does not promote or offer direct-to-consumer treatments. All clinical use of Dezawa MuseCells® must occur under licensed, ethics-reviewed, and jurisdictionally approved frameworks. This site is intended for institutional, clinical, and scientific audiences only. All published information utilizes Dezawa MuseCells® that are manufactured in accordance with MCI’s patented processes.